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Abstract 
 
Purpose: The objective of this study was to evaluate the osseointegration between 
plasma sprayed (PS) hydroxyapatite (HA) coated implants and electrophoresis deposited (EPD) 
nano hydroxyapatite coated implants in an animal model.  The quantity of osseointegration was 
inferred by interfacial strength and percent tissue-contact length.  Materials and Methods: 
Thirty-six cylindrical implants (18 PS and 18 EPD) were placed into dog mandibles.  Nine 
implants from each group were evaluated with pull out testing and histological studies at 12 
weeks after implantation.  The remaining implants were occlusally loaded for 9 months and then 
evaluated by pull out testing and histological studies.  Results: Twelve weeks after implantation, 
no statistical difference in pull out strength was observed between PS HA (70.43 ± 16.65 lbf) and 
EPD nano HA (86.35 ± 28.07 lbf) coated implants . After loading for 9 months, it was observed 
that the interfacial strength of implants coated by EPD nano HA (199.9 ∀ 35.1 lbf) was 
statistically higher (P <0.028) than the PS HA coated implants (121.14 ± 38.45 lbf).  At 12 
weeks implantation, no statistical significant difference in bone contact length was observed 
between EPD nano HA (97.6 ± 3.2%) and PS HA coated implants (95.6 ± 4.6%).  No statistical 
significant difference in tissue-contact length was observed between EPD nano HA(91.8 ± 8.2%) 
and PS HA coated implants (84.3 ± 7.2%) after loading for 9 months.  Discussion: The 
advantages of PS HA coatings are widely recognized, but little data exists on rate and quantity of 
osseointegration relative to newer coating methodologies such as electrophoresis deposition.  
EPD nano HA shows promise as a HA implant coating process, achieving higher interfacial 
strength than the PS HA coating after 1 year in this study. Conclusion: Histological data and 
interfacial strength suggest that PS and EPD nano HA coated implants achieve similar bone 
responses short term.  However, EPD nano HA coated implants attained a higher interfacial 
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strength after 9 months of loading, even though histological data was not statistically different 
from that of PS HA coated implants.  
 v
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Chapter 1. Introduction 
 
1.1. Early History of Dental Implants 
Tooth loss due to disease and trauma is as primitive as reality of replacement of teeth.   
Modalities of tooth replacement have evolved and today are only limited by available dental 
materials and technologies.  The debilitating effects of tooth loss on general health and 
appearance were appreciated even in ancient times.  Throughout history, teeth have been 
replaced, shaped, and veneered to show wealth and power as well as to enhance beauty. Ancient 
Incas and Egyptians were known to tap precious metals, sea shells and even human teeth into the 
jaw to replace missing teeth.  Ancient Etruscans replaced missing teeth with the teeth of oxen or 
calves and even practiced dental prosthetics using gold bands affixed to artificial replacements 
(Ring 1985). 
Dentistry as a profession was recognized in the Middle Ages.  During the Early Middle 
Ages in Europe, monks were educated to practice medicine, surgery, and dentistry. However, 
from 1130 to 1163, a series of Papal edicts prohibited monks from performing any type of 
surgery.  It was the barber who often assisted monks in their surgical ministry that assumed the 
monks’ surgical duties: bloodletting, lancing abscesses, extracting teeth, etc (Ring 1985). 
In 1210, the Guild of Barbers was established in France.  Barbers eventually evolved into 
two groups: surgeons who were educated and trained to perform complex surgical operations; 
and lay barbers, or barber-surgeons, who performed more routine hygienic services including 
shaving, bleeding and tooth extraction (Ring 1985). 
In 1809, the French dentist Maggiolo published Le Manuel de l’Art du Dentiste.   He 
described how he cast a gold root-shaped implant, inserted it into a fresh extraction socket, and 
then attached a prosthetic tooth after a certain healing period (Maggiolo 1809).  Sixty years later, 
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S.M. Harris described a technique in which he artificially created a socket to implant a roughed 
lead metal coated porcelain post (Dental Cosmos 1913).  In 1886, Edmunds was the first 
clinician in the US to implant a platinum disc into the jawbone, to which he attached a porcelain 
crown.  His efforts were accounted for at the First District Dental Society of New York (Ring 
1995).  Based on these and several other observations, many more implantation attempts were 
made, experimenting with different metal alloys and porcelain formulations; however, on the 
whole, the long-term success rates were still very poor. Modern dental treatment focuses on 
preservation of the oral hard and soft tissues as well as the replacement of defective or lost 
dentition.  Because tooth loss is as common and problematic as it was thousands of years ago, 
considerable research has focused on the prosthetic replacement of teeth.   
 
1.2. Modern History of Dental Implants 
In 1937, Alvin Strock inserted the first dental screw implant made of cobalt-chromium-
molybdenum alloy.  This first successful biocompatible implant metal, otherwise known as 
vitallium, had been developed a year earlier by Charles Venable, an orthopedic surgeon. These 
were among the first somewhat successful oral implants.  Strock published a paper on the 
physiological effects of vitallium in bone.  He noted that implants made of vitallium had few 
post-operative complications or reactions in test animals and humans. Histologic sections 
demonstrated remarkable tissue tolerance to the vitallium implants. Strock documented long term 
success up to 15 years, until he passed away (Strock 1939, Strock 1949, Cranin 2006). 
From the mid 1930’s, implant concepts developed which formed the foundation for 
today’s variety of implant modalities.  Efforts to improve osseointegration influenced the 
fabrication of many implant geometries.  These designs include subperiosteal, transosseous and 
endosteal implants. 
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The subperiosteal implant design is a nonosseointegrated, metal framework that rests 
beneath the mucoperiosteum of the jaw bone.  The framework has posts which pierce the mucosa 
in order to attach to an overdenture.  Problems associated with subperiosteal implants include 
damage to underlying bone, infection, difficulty of removal, and epithelial down growth with 
subsequent dehiscence of the frame (Worthington 1994).  A retrospective study at the University 
of Southern California recorded follow up, maintenance, and treatment of complications in 81 
mandibular subperiosteal implants placed at the Advanced Prosthodontic Clinic for periods up to 
21 years. The 10-year survival rate for subperiosteal implants was calculated at 79% for 63 
patients, and a 15-year survival rate of 60% was calculated for 34 patients. Researchers 
concluded that subperiosteal implants’ long term survival rate declines over time.  And although 
subperiosteal implants long term survival rates were poor, they were successful in providing 
support and retention to patients that that could not otherwise tolerate dentures (Yanase et al. 
1994). 
Transosseous implants are a surgically invasive implant design in which bicortical posts 
are inserted through a submental incision under general anesthesia. A common design is the 
transmandibular staple.  The staple has a plate which fits against the lower border of the 
mandible.  It is stabilized by posts that penetrate to the superior border of the mandible.  These 
posts attach to an overdenture (Worthington 1994).  Meijer et al. (1998) evaluated mandibular 
staple implants in a long-term retrospective study that included fifty-six edentulous patients over 
a mean evaluation period of 103 months.  Results indicate a survival rate of 91%.  Though long 
term success rates are comparable to other more common implant modalities, less invasive 
implant systems such as endosseous implants are preferred by operator and patient.
Endosseous implants as a whole have experienced an evolution of designs.  Such designs 
include the blade and root shaped cylinder or threaded forms.  The most common geometry used 
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today is the root shaped threaded implant.  Root shaped implants can be placed in the maxilla or 
mandible and have vast restorative capabilities with good long term success rates (Worthington 
1994).  The long term survival of endosseous implants has been attributed to its ability to 
become osseointegrated.  The process of osseointegration and implants was first described in the 
literature by Brånemark et al. in 1981.  Initial research suggested direct bone-to-implant interface 
contact at the electron microscopic level.  They concluded than osseointegrated implants were a 
reliable, cement-free anchor for permanent prosthetic substitutes (Albrektsson et al.1981). 
 
1.3. Osseointegration 
The mechanism of attachment of the implant to the bone has been evaluated though a 
variety of materials and geometries.  For some years, clinicians sought to develop an analogue of 
the periodontal ligament to attach implants to bone.  But as previous clinical evidence would 
hold true, replicating nature to artificially replace teeth is not always possible.  The connective 
tissue sheath created in preliminary research histologically lacked organization and specialization 
necessary to truly function as the periodontal ligament.  Loading implants sheathed in connective 
tissue increased the fibrous tissue layer, subsequently loosening the implant to failure (Weiss 
1990). 
In 1952 that Swedish professor Per-Ingvar Brånemark began his work on tissue 
integrated prostheses.  His objective was to understand the healing and reparative capacity of 
hard and soft tissue in order to obtain a predictable tissue response to implant therapy.  The 
pursuit of osseointegration and dental implants stemmed from microscopic studies bone marrow 
of the rabbit fibula.  Intravascular examination revealed the intimate circulatory connection of 
bone and marrow during regeneration after surgical insult.  In addition, mechanical, thermal, 
chemical and rheological tissue injury was reported in order to develop surgical procedures with 
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predictable healing of differentiated tissues (Brånemark 1983).  
In the early 1960’s, Brånemark implanted screw shaped titanium chambers into animals.  
It was noted that chambers were “inseparately incorporated” into bone.  Microscopic 
examination revealed bone had actually grown into the surface pores of the titanium.  Separate 
studies evaluated healing and anchorage stability related to various sizes and designs of titanium 
implants. Brånemark found that titanium fixtures implanted into the marrow cavity would form a 
shell of cortical bone devoid of a fibrous tissue interface around the implant.  This direct bone to 
implant interface between vital bone and the screw-shaped titanium implants was proven to 
achieve and maintain bone anchorage under loading.  Brånemark and associates described this 
phenomenon as osseointegration, to describe the “direct structural and functional connection 
between ordered, living bone and the surface of a load carrying implant.”  In 1965, the concept of 
osseointegration and dental implants was proposed to maintain a dental prosthesis in an 
edentulated human (Albrektsson et al. 1981).  
In 1983, Brånemark described osseointegration and its experimental background.  
Brånemark subsequently demonstrated that with a carefully controlled surgical technique, 
titanium could be predictably implanted and integrated into vital bone.  In dentistry, these 
findings implemented a new direction of implant experimental design and research. 
 
1.4. Bone Physiology 
Endosseous implants rely on bone for support and anchorage.  Therefore it is important to 
understand the physiology, structure and metabolism of unaltered bone as well as its response to 
surgical, healing and post operative conditions.  Bone is connective tissue that consists of a 
complex composite of cells and extracellular matrix.   Bone cells include osteocytes, 
osteoprogenenitor cells, osteoblasts and osteoclasts.  Each of these cells is related to different 
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functions of cell activation, matrix maturation, mineralization and remodeling.  The extracellular 
matrix contains type I collagen and ground substance.  Ground substance is an aggregate of 
proteoglycans and noncollagenous glycoproteins that become mineralized.  These minerals 
include calcium and phosphorus and are stored as hydroxyapatite crystals [Ca10 (PO4)6 (OH)3] 
(Roberts 1987).  Through mineralization, bone obtains its rigid structure and function: support 
and protection of the musculoskeletal system and a physiologic reservoir of calcium and 
phosphorus.  Other connective tissues included in bone are hemopoietic, vascular, neural and 
adipose tissue as well, hyaline and articular cartilage (Whitson 1998).  
Bone is classified in several ways.  Clinically, bone can be recognized by density and 
structure.  Dense compact bone forms an outer shell for an inner meshwork of anastomosing 
spicules of cancellous bone.  Its shape further identifies bone as long bones, short bones, flat 
bones or irregular bones (Whitson 1998). 
Microscopically, bone can be subdivided into woven and lamellar bone.  Woven bone is 
formed during growth and development and in response injury.  It consists of highly cellular 
osseous tissue with low mineral content, random fiber orientation and minimal strength.  It can 
be formed at a rate of 30-50um/day or more and is replaced with lamellar bone.  Woven bone is 
essential to initial healing of endosseous implants.  Lamellar bone is the mature load bearing 
bone that comprises most of the adult skeleton.  This bone is densely mineralized and highly 
organized into three distinct structural units.  These units create the Haversian system which 
encase the neural and vascular tissue of bone. Circumferential lamellae form a perimeter of 
compact bone that encases concentric and interstitial lamellae.  Concentric lamellae encase 
Haversian canals to form osteons.  Interstitial lamellae are irregular shaped remnants of 
concentric lamellae (Ross et al. 1995). 
Although osseointegration occurs with predictable success, biological understanding of 
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early cellular events leading to osseointegration of implants is currently deficient.  
Histomorphometric and histologic analyses are often from animal models (Clokie and 
Warshawsky 1995, Sleats et al. 2006).  However, the basic understanding of bone remodeling 
helps to describe the process of osseointegration. 
Remodeling describes the dynamic ability of old or damaged bone to be replaced by new 
bone.  The rate of turnover is approximately 5% for cortical bone and up to 15% for trabecular 
bone. Old bone is resorbed by osteoclasts which form a cutting cone.  Osteoblasts differentiate 
behind the cutting cone to form the filling cone.  Osteoblasts in the filling cone synthesize 
osteoid which becomes the mineralized osteons.  Osteoblasts differentiate into osteocytes during 
mineralization and maturation of bone (Whitson 1998).  The surgical placement of implants 
damages bone and initiates bone remodeling. 
Block et al. (1997) divides bone healing and remodeling after implant surgery into three 
phases: the inflammatory, proliferative and maturation phase.  Each phase is distinct, but there is 
overlap of specific occurrences in transition from one phase to another.  The inflammatory phase 
occurs in the first ten days after surgical insult and is characterized by adsorption of plasma 
proteins, platelet aggregation, clotting cascade activation, cytokine release, nonspecific cellular 
inflammatory response, macrophage-mediated inflammation. The proliferative phase occurs 
from day 3 to 42 and is characterized by neovascularization, differentiation, proliferation and 
activation of cells and production of immature connective tissue matrix.  The maturation phase 
occurs after day 28 and is characterized by remodeling of the immature bone matrix with 
coupled resorption and deposition of bone, in response to implant loading and physiologic bone 
recession.
Slaets et al. (2006) describes early cellular responses to titanium implants placed in the 
rabbit tibia.  Upon placement of an implant, a coagulum of blood fill the fills the microgap 
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between the implant and bone.  One week after insertion, osteoclasts and osteoblasts were 
observed at the bone surface.  The osteocytic lacunae of the damaged bone appeared to be devoid 
of cells for up to 28 days (P <0.05) after implant insertion. This region of altered nuclear 
morphology was accompanied by an invasion of basic multicellular units (BMUs) that initiated 
bone remodeling, which reached its maximum after 4 weeks (P <0.05) but was ongoing 6 weeks 
after implant insertion.  Intensive bone remodeling resulted in the formation of new bone, 
eventually leading to the osseointegration of the implant.  Understanding bone remodeling and 
the capacity in which bone can heal is fundamental to formulating new implants that predictably 
integrate with reduced healing time.  
 
1.5. Endosseous Implants 
Endosseous implants have become a paramount option in the treatment planning of single 
tooth replacement, fixed partial dentures, removable partial and complete dentures, and 
prosthetic maxillofacial reconstruction.  As implant technology evolves, so must the 
understanding of the biologic principles that control the ability of the body to tolerate and 
maintain the artificial replacement of lost tooth structure and adjacent periodontium.  
 
1.5.1. Composition  
In order to achieve success, implants must be made of a material that is biocompatible. 
Accepted materials used in the fabrication of implants are classified into three groups: metals, 
ceramics, and polymers.  Each material can be further identified by is biocompatibility as 
bioinert, biotolerant, and bioactive. Bioinert materials allow close apposition on their surface, 
leading to contact osteogenesis.  Materials considered bioinert include ceramics such as 
aluminum oxide and zirconium oxide, and metals such as commercially pure titanium and 
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titanium alloys.  Biotolerant materials are not rejected when implanted in tissue, but are 
surrounded by a fibrous layer to form a capsule.  Biotolerant metals and polymers encompass 
gold, cobalt-chromium alloys, stainless steel, zirconium, niobium, tantalum, polyethylene, 
polyamide, polymethylmethacrylate and polytetrafluorethylene.  Bioactive materials allow for 
formation of new bone on their surface, exchanging ions to create a chemical bond.  Polymers 
used as bioactive implant materials include hydroxyapatite, tricalcium phosphates, tetracalcium 
phosphates, calcium phosphates, fluorapatite, brushite, carbon: vitreous and pyrolytic, carbon-
silicon and bioglass. Bioactive and bioinert materials are osseoconductive, meaning they form a 
scaffold for bone ingrowth, making them prevalent dental implant research and production 
(Sykaras et al. 2000).  
The magnitude of parafunctional loads has eliminated most materials with adequate 
biocompatibility but poor physical properties such as silicone, hydroxyapatite and carbon from 
use as a primary implant biomaterial.  However, the combination of excellent biomechanical and 
physical properties of titanium and titanium alloys in dental and orthopedic implants has yielded 
a long history of success (Cho and Park 2003).  Titanium is the 22 element on the periodic table.  
Its anatomic structure is 1s2, 2s2, 2p6, 3s2, 3p6, 3d2, and 4s2.  The electrons 3d2 and 4s2 are highly 
reactive and form obstinate oxides, mainly TiO2, responsible for its biocompatibility.  
Commercially pure titanium is available in four grades based on corrosion resistance, formability 
and strength.  It contains dissolved oxygen, nitrogen, carbon, hydrogen and aluminum.  The 
addition of aluminum and vanadium (Ti-6Al-4V) to titanium to create titanium alloys enhances 
the elastic modulus, ultimate tensile strength and yield strength (McCracken 1999).   
 Many surface modifications to titanium implants have been introduced in order achieve 
better bone apposition and implant to bone contact.  Efforts have been made to enhance the oxide 
layer by thermal and anodic oxidation, sandblasting, acid etching and ionic implantation. 
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(Wisbey et al. 1991, Zhu et al. 2001, Cochran et al. 2005, Nayab et al. 2007).  Another approach 
to surface modification is the addition of a biochemical surface coating to a titanium substrate.  
These substrates include bioactive peptides, proteins, and calcium and phosphate based ceramics.  
Hydroxyapatite is a calcium and phosphate based bioceramic of particular interest to the implant 
coating industry due to its similar structural and chemical composition to bone (Kato et al. 1979, 
Nanci et al.1998). 
 
1.5.2. Design 
The design of an implant can be characterized by combination of elements that compose 
its three-dimensional structure.  Elements and characteristics that compose implant design 
include the type of prosthetic interface, the presence or absence of threads, additional 
macroirregularities, and the shape/outline of an implant (Sykaras et al. 2000).  Additional 
features such as vents, grooves, flutes, indentations, and perforations have been added by many 
implant manufacturers to accentuate or replace the effect of threads.  Parallel, tapered (conical), 
or stepped implant outlines can be made hollow or solid, and with a flat, round, or pointed apical 
end (Steigenga et al. 2003). 
 
1.5.3. Surface Topography 
The submerged portion of the implant can be described by its topography.  Ideal implant 
topography would enhance osseointegration, thus many unique surfaces are commercially 
available. A consensus of literature indicates that implant enhancements associated with surface 
roughness improve adhesion to bone, if only by mechanical interlocking (Baier and Meyer 
1988).  Roughening an implant has been demonstrated to increase the surface area available for 
bone to implant contact.  The increased surface area of a roughened implant has been positively 
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correlated by Buser et al. (1991) to increased biomechanical anchorage to bone.  Some in vitro 
studies suggest surface roughness may influence osteoblast proliferation, differentiation, 
attachment and matrix production (Martin et al. 1995).  Cooper et al. (1999) demonstrated a 
diminished expression of bone sialoprotein and osteocalcin with decreased mineralization of 
fetal bovine mandibular osteoblasts when adjacent to a plasma sprayed titanium surface as 
opposed to titanium oxide grit-blasted surface.  They concluded that different surface 
topographies do in fact influence unique organic and inorganic deposits during matrix formation. 
Few quantitative recommendations for surface topography are documented owing to the 
vast influx of commercially available surface topographies.  MacDonald et al. (2004) expounded 
on the ambiguity of quantifying surface texture.  Examiners sent seven implants of significantly 
different surface textures to three internationally renowned laboratories for surface texture 
characterization.  Measurement techniques included contact profilometry, two- and three-
dimensional laser profilometry, and atomic force microscopy.  Four to thirteen parameters were 
reported.  Thus, implant surfaces are often described by the mechanism in which they are made.   
Roughened surfaces are achieved either by many mechanisms including plasma spraying, 
blasting, etching or sintering implants.  Plasma spray (PS) coatings of titanium or hydroxyapatite 
are most commonly applied to the metallic core of an implant.  PS particle size, speed, time of 
impact, temperature and distance impacts the thickness of the coating (Ong et al. 2006).  
Titanium oxides and aluminum oxides of various particle diameters are used to abrade 
the surface of implants.  Grit blasting creates a surface of irregular pits and depressions.  The 
particle size, time, pressure and distance create a range of desired surface roughness (Sykaras 
2000).  Feighan et al. (1995) affirmed that blasting polished titanium implants with 30 and 60 grit 
aluminum oxide resulted in significantly more bone formation on the implant as well as a higher 
shear strength at the implant-bone interface as compared to a polished titanium surface alone. 
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The disadvantage to grit blasting is the potential for particles to remain embedded on the 
implant surface disrupting osseointegration (Orsini et al. 2000). Chemical exposure of a metallic 
implant to acid etches may enhance osseointegration without adding particulate matter or surface 
contaminants, eroding pits of specific dimension and shape (Sykaras 2000).  Cho and Park 
(2003) concluded that acid etched implants have a greater resistance to torque removal compared 
to machined surface titanium.  These results are interpreted as an increase in implant to bone 
contact.  A combination of blasting and etching has recently been introduced.  Buser et al. (1998) 
found that blasted and etched surfaces has increased removal torques over etched only surfaces, 
suggesting increased bone to implant contact and anchorage. 
Porous surfaces are differentiated from roughened surfaces by the lack of sharp or jagged 
topography.  Pores are created by sintering spherical powders of metallic or ceramic materials to 
the metallic core of an implant. The pore size, shape, depth, and volume are affected by the 
particle size and temperature and pressure of the sintering process (Pilliar 1998). Maximum bone 
ingrowth appears to occur at a poor depth of 150-300 µm (Bobyn 1980).  The pore volume 
(porosity) directly affects the strength of the sintered coating to contact metal (Hoffman 1997).
  
1.6. Hydroxyapatite 
 
1.6.1. Background 
In 1788, A.G. Werner identified a brilliantly colored crystalline mineral which he would 
term apatite (Dana 1951).  Its name in Greek is translated “to deceive”, because it had been 
mistaken for precious gems such as beryl, tourmaline, chrysolite and amethyst (Wei et al. 2005).  
Some 40 years later, G. Rose would postulate that apatite, a natural phosphate, may contain 
"atoms" of either chloride or the fluoride.  Apatite is one of few minerals that are produced and 
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used by biological systems (Dana and Dana 1920).  
Hydroxyapatite (HA) is composed of calcium, phosphorus, oxygen and hydrogen [Ca10 
(PO4)6 (OH)2].  The chemistry of HA lends itself to be similar to the mineral content of hard 
tissues such as bone and teeth in vertebrates (Whitson 1998).   Therefore, significant efforts in 
multidisciplinary research have sought to implicate the use of HA for numerous scientific 
applications such as separation and purification of proteins, drug delivery systems and bone 
implants (Koutsopoulos 2002, Suen et al. 2004, Wahl and Czernuszka 2006). For each 
application, the use of the calcium phosphate based material is optimized by specifying its 
geometry, dimension, density, pore size, mechanical strength, purity, and chemical phase. 
 
1.6.2. Dental Implant Uses 
Implant surface chemistry and topography are correlated to tissue response and fixation 
in bone.  Therefore, the inherent bioactivity of HA lends itself to much research for implant 
composition (Hacking et al. 2002).  Although HA has excellent biocompatibility, the brittle 
nature of HA makes it unacceptable for load bearing applications.  Therefore, HA was developed 
as coating for dental and orthopedic implants to combine the bioactive surface of HA with the 
strength of titanium (Sykaras et al. 2000). The advantages of HA coatings lie within its reported 
osseoconductive ability to improve the rate and strength of initial implant integration.  Enhanced 
integration could result in earlier and improved stability for prosthetic loading (Jarcho 1992).  
Many clinical and laboratory studies have been undertaken to evaluate the 
biocompatibility of HA coated implants.  Laboratory research by Thomas et al. (1989) concluded 
that early bone growth and apposition are accelerated by implants coated with HA.  A study by 
Weinlaender M. et al. (1992) was designed to quantify the amount of bone in contact with three 
different implants placed in mongrel dogs.  These implants included threaded titanium, flame 
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sprayed titanium cylinder and HA coated titanium cylinder.  Results indicated that HA coated 
implant had a significantly greater contact with bone than the other implants.  Block et al. (1997) 
found that CaP coated Ti implants stimulated bone formation at an earlier and faster rate than 
non-coated implants. However, Hacking et al. (2002) attributes the increased osseoconductive 
tissue response a possible result from surface topography and not bioactivity of HA coatings.  
This article suggests that the similarity of surface roughness in HA and titanium is often 
unaccounted for in research designs. Therefore, they designed an experiment to mask HA 
chemistry while maintaining equivalent surface topographies.  Although HA surface coating 
showed significantly more bone apposition, 80% of apposition could be attributed to the surface 
topography.  Wheeler (1996) cited no statistically significant difference in survival rate between 
HA and grit blasted titanium.  
 
1.6.3. Preparation 
 HA is a stable calcium phosphate salt found in bone and naturally produced as a result of 
cartilage arthritis, formation of renal and bladder stones, and calcification of cardiac valves 
(Schwille et al. 2005, Suvorova and Buffat 2005, Reginato and Olsen 2007).  Its medical and 
pharmacological implications have necessitated the production of well-defined, synthetically 
pure HA crystals.   Several methods of production are reported, including solid state reactions, 
plasma techniques, crystal growth under hydrothermal conditions, layer hydrolysis, and sol-gel 
crystallization.  However, non-stoichiometric products are the result of synthetic processes.  The 
presence of crystal lattice vacancies and ions such as carbonates, hydrogen phosphates, 
potassium, sodium, nitrates and chloride combined with the high affinity of HA molecules to 
these ions easily contaminates  and changes the cystallograpic characteristics and morphology of 
HA (Koutsopoulos 2002).  
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 Commercially available HA grain size is available from 45 to 160 micrometers (Zheng 
2000).  However, the large grain size of conventional HA may contribute to its physical 
weaknesses.  Smaller, denser HA feedstocks are the focus of commercial production of 
bioceramics today.   
The concept of technological opportunity on the scale of atoms and electrons was 
introduced at the annual meeting of the American Physical Society in 1959 by Caltech scientist 
Richard Feynman (Appenzeller 1991).  Feynman coined this science Nanotechnology, which 
today refers to the field of science focused on the development of nanometer sized materials, 
devices and systems.  The size dependant physical properties of materials reduced to the 
nanoscale can suddenly show very different characteristics compared to what they exhibit on a 
macroscale, enabling unique applications (Salata 2004).  With this knowledge, the use of 
nanotechnology by the implant industry has lead to the creation of nanosized bioceramics such as 
nano HA to overcome physical, chemical and biological limitations of conventional HA.  
  
1.6.4. Composition 
 HA is chemically similar to bone mineral, but not in physical properties and 
microstructure. Bone is a nanocomposite composed of a collagen-fiber-reinforced 
microstructure, lending itself to be mechanically tough (2-12 MPa.m1/2) as well as plastic.  
However, HA is a brittle polycrystalline ceramic with low fracture toughness (.6-1.5 MPa.m1/2) 
(Hench 1991, Salata 2004). 
The chemical composition of HA coating can vary in percent composition of crystalline 
HA, alpha and beta tricalcium phosphates, calcium oxides, calcium pyrophosphates, and 
amorphous CaP.  HA coating crystallinity, phase composition, quantity and type of porosity all 
determine the reactive properties and subsequently the osseointegration potential of the coating.  
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Surface reactions include the following cascade of events including the dissolution of HA, 
precipitation of the apatite, ion exchange accompanied by absorption and incorporation of 
biological molecules, cell attachment proliferation and differentiation, and extracellular matrix 
formation and mineralization (Xue 2005).   
Dissolution is reported by Ducheyne et al. (1993) to be crucial to the induction of apatite 
precipitation on the surface of HA coatings to initiate osseointegration.  However the rate of 
dissolution must be balanced between enhancement of bioactivity and detrimental effects of 
coating disintegration, resulting in the loss of bond strength and implant fixation. (Schepers et al. 
1991, Wheeler 1996).  The rate of dissolution is associated with the crystallinity of a prepared 
HA coating.  The crystallinity of HA describes the percent of chemical composition in crystalline 
form within any given HA coating.  The rate of dissolution is affected by the ratio of crystalline 
HA to metastable compounds such as amorphous calcium phosphate (ACP), calcium oxide 
(CaO), α-tricalcium phosphate (α-TCP), β-tricalcium phosphate (β-TCP), and tetracalcium 
phosphate within HA that are either inherent or produced during the application of the coating to 
an implant subtrate.  These metastable constituents are more soluble that crystalline HA; 
therefore, increase dissolution (Xue 2005).   
 
1.6.5. HA Coating Methodologies 
Implants are coated with HA through various methodologies.  An ideal coating must be 
biocompatible at its desired phase and crystallinity to enhance biological response, have 
sufficient mechanical characteristics to maintain the integrity of the coating-implant interface, 
and possess adequate porosity to promote bone in growth and fixation (Cahn et al. 1993).   HA is 
most commonly applied by plasma spraying and electrophoresis deposition.  The investigation 
for optimal coating properties has led to other experimental coating methodologies that include 
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ion beam sputter deposition, sol-gel processing and high velocity flame sprayed deposition.   
The PS process is a type of thermal-spray technology that uses a device to melt and 
deposit a coating material at a high velocity onto a substrate.  PS HA onto dental implants is 
accomplished under normal atmospheric conditions.  A direct-current electric arc created by a 
high current, low voltage electrical discharge between two electrodes produces a plasma flame.  
The arc super heats a carrier gas stream that contains the molten HA powder.  The HA is 
deposited onto the implant by the plasma flame.  Adhesion of the HA to titanium is purely 
mechanical and can be enhanced by a roughened substrate surface (Herman 1988, Ong et al. 
2006). 
Structural and chemical properties are modified by power, currents, plasma work gas rate 
and composition, carrier gas rate, spraying time, particle size, speed of the plasma, distance 
between substrate and nozzle and cooling rate.  The plasma work gas composition is the most 
important spraying parameter in regulating the desired crystallinity, heat content and coating 
thickness of HA.  An argon carrier gas can be infiltrated with other elements to change coating 
properties.  For example, introducing hydrogen will result in a higher crystallinity and hotter 
plasma, whereas nitrogen can produce a thicker coating layer (Ong et al. 2006).  Commercially 
available PS coatings are reported to have a thickness of greater than 30 micrometers (Herman 
1988).  Surface roughness of PS HA coated implants can range from Ra= 3 to 8 micrometers 
(Hacking 2002).   
The advantages of PS include simplicity, rapid deposition rate, low substrate temperature, 
low cost and variable coating porosity, phase, and structure and low cost.  The disadvantages 
associated with PS HA coatings are attributed to over 100 operational variables associated with 
spraying process that ultimately affect the final coating’s  microstructure and physical properties 
(Cheang and Khor 1996).  Reported problems include poor bond strength between coatings, HA 
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adhesion to its substrate, structural and chemical variation within the coating process, and 
variation between commercial vendors of HA coatings (Wennerberg et al. 1993, Zheng et al. 
2000, Khor et al. 2003).   
To improve the mechanical integrity and biological and physical properties of PS HA, 
research has focused on incorporating functionally graded coatings and post-spray heat 
treatments. Functionally graded HA coatings incorporate dissimilar materials such as titanium 
alloys enhance mechanical properties.  Chen et al. (2006) determined functionally graded HA/Ti 
composite coatings had superior mechanical properties over monolithic HA coatings.  Zheng et 
al. (2000) concluded that incorporating titanium to HA coating would significantly improve the 
bond strength of the PS coating.  Khor et al. (2003) found that a graded distribution of HA and 
Ti-6Al-4V phases in FGM coatings improved the tensile adhesion strength significantly.   
Post spray heat treatment affects the HA coating phase by increasing crystallinity.  The 
desired crystallinity of HA coating is of much dispute.  Ding et al. (2003) found that annealing 
HA coatings in air at 650° C led to recrystallization of amorphous CaP, increasing crystallinity 
and reducing residual stresses of the apatite.  However, Porter et al. (2002) noted annealing HA 
coatings resulted in prolonged timing of apatite deposition due to the reduced dissolution of the 
heat treated coating.   
Electrophoresis deposition (EPD) is a process in which colloidal particles such as HA 
nano precipitates are suspended in a liquid medium migrate under the influence of an electric 
field and are deposited onto a counter charged electrode. Pressure is concurrently applied to HA 
nano particles against the electrode. The coating is simply formed by pressure exerted by the 
potential difference between the electrodes (Birks and Schulman 1959). 
The operational parameters of EPD can be changed to alter HA surface coating 
morphology and composition.  These parameters include the voltage/intensity relationship, 
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deposition time, and composition, pH and temperature of the electrolyte (Meng et al. 2006, 
Wang et al. 2006).  The process of EPD is described by Hamaker's equation, which relates the 
electrophoretic velocity to a function of the electric field and particle size: 
 
υ = Q E / 4 π r η                  (Eq.1) 
 
where Q is the charge,  r is the particle radius, E is the potential difference applied to the 
suspension of the electric field, and η is the suspension viscosity (Mondragon-Cortez and 
Vargas-Gutierrez 2004).  It is inferred that small HA particles gain the highest electophoretic 
velocity and are deposited at a lower velocity to create a denser coating.  A higher suspension 
velocity would deposit larger HA particles on a substrate at a faster rate resulting in a more 
porosity of the coating (Meng et al. 2006). 
Studies done by Meng et al. (2006) confirmed that a low voltage of 20 V created a 
coating of fine, dense HA particles (150-200 nm).  However, a constant high voltage of 200V  
created a porous surface composed of large HA particles (>400nm).  By applying a dynamic 
voltage, authors were able to create a graded coating of particle size and porosity.  They also 
noted that post deposition sintering resulted in a denser, more adhesive coating on the substrate.  
The reported advantages of EPD encompass its low cost, simple methodology capable of 
producing coatings of variable thicknesses, high deposition rate, formation of highly crystalline 
deposits with low residual stresses and ability to uniformly coat non-line-of-site, irregularly 
shaped, or porous objects such as threaded implants due to its high throwing power (Meng et al. 
2006, Wang et al. 2006).  EPD can produce HA coatings ranging from <1 micron to >500 
microns thick (Wei et al. 2005).  Surface patterns created on the EPD cathode have been shown 
to create a patterned HA coating on an implant substrate to change surface topography and 
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enhance osseointegration (Wang and Hu 2003). 
The major disadvantage is EPD is the need for post deposition heat treatment to densify 
the coating (Wei et al. 1999).  Conventional HA feedstocks require temperatures of at least 
1200° C to be densified (Ruys 1995, a).  Temperatures above 1050° C affect the oxide layer and 
mechanical properties of a stainless steel or titanium alloy, as well as decompose HA affecting 
the interfacial strength between the metal and coating (Ducheyne 1990).  To obtain lower 
temperatures for densification, ultrafine HA powders were developed in the range of 0.01 to 0.1 
micrometers (nanoparticulate), achieving a plateau density of 100% at 1000° C (Ruys 1995, b).  
Wei et al. (1999) evaluated the optimization of the properties in production of HA nanoparticles 
for use in EPD methodology, concluding ambient-aging ripening for 10 days eliminated cracking 
in the electrophoretic coating.  Further research by Wei et al. (2005) noted several methodologies 
for producing HA nano precipitates, confirming the metathesis produced highly equiaxed nano 
particles, lending to less cracked coatings obtained by the electrophoretic deposition technique.  
Hu et al. (2007) confirmed with the Raman and IR spectra that the main component of EPD 
coatings is well crystallized with excellent bioactivity and biocompatibility. 
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Chapter 2. Problem and Research Objectives 
 
2.1. Research Problem 
Hydroxyapatite coatings have significant biologic potential as a surface modification for 
dental implants.  However, an optimal HA application modality must be identified.  The current 
study evaluated two HA coating methods and intrinsic differences in coatings relative to 
application processes. 
 
2.2. Research Objectives  
The goal of this research was to compare electrophoresis deposited nano HA coated 
implants with plasma sprayed HA coated implants. The following aims and hypotheses were 
developed for this study: 
 
Specific aim I: To evaluate the interfacial strength and bone-contact length of the two 
different HA coated implants following 12 weeks in situ before loading. 
Hypothesis I.I: No difference in bone contact length will be observed between the 
electrophoresis deposited nano HA coated implants and plasma sprayed HA 
coated implants following 12 weeks in situ before loading. 
Hypothesis I.II: No difference in and interfacial strength will be observed between the 
electrophoresis deposited nano HA coated implants and plasma sprayed HA 
coated implants following 12 weeks in situ before loading. 
Specific aim II: To evaluate the interfacial strength and bone-contact length of the two 
different HA coated implants after loading for 9 months. 
Hypothesis II.I: No difference in bone contact length will be observed between the 
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electrophoresis deposited nano HA coated implants and plasma sprayed HA 
coated implants after loading for 9 months. 
Hypothesis II.II: No difference in interfacial strength will be observed between the 
electrophoresis deposited nano HA coated implants and plasma sprayed HA 
coated implants after loading for 9 months. 
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Chapter 3. Materials and Methods 
 
3.1. Experimental Plan 
Thirty-six cylindrical implants (4 mm diameter by 8 mm long) were obtained (“O” 
Company, OCO Biomedical, Inc., Albuquerque, NM).  Eighteen implants were plasma sprayed 
(PS) with HA and 18 were coated with electrophoresis deposited (EPD) nano HA coatings. 
Interfacial histological and mechanical strength were recorded through qualitative methods to 
compare coating methodologies. 
 
3.2. Samples 
Six adult male foxhound dogs (approximately 2 years old), weighing between 20 to 25 
kg, were used in this study. All animals used in the study were managed in compliance with 
USDA program and NIH publication # 85-23, “Guide for the Care and Use of Laboratory 
Animals.” Policies, standards and guidelines for the proper use, care, handling, and treatment of 
animals were followed. Surgery intervention consisted of two operations; mandibular posterior 
sextant tooth extractions and implantation.  All dogs were kept NPO 12 hours prior to surgery.  
Prior to extractions, the dogs were maintained on Purina Canine Lab Chow (Purina Mills, St. 
Louis, MO).  Following extractions, the dogs were fed Pedigree (Kal Kan Foods, Inc. Vernon, 
CA) soft canned dog food. 
 
3.3. Instrumentation and Equipment 
Three months prior to implantation, extraction surgery was performed. Anesthesia was 
induced using sodium pentothal (Abbott Laboratories, Chicago, IL). The dogs were intubated 
and maintained with vaporized 0.80-1.0% halothane (INEOS Fluor Americas LLC, St. Gabriel 
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LA). The animals were maintained on a ventilator.  Lactated Ringer’s solution was administered 
at a slow drip. Prior to surgery, the dogs received Penicillin BP (3 cc every other day) and 
Gentocin (2 cc SID) subcutaneously as an antibiotic prophylaxis. Extractions were accomplished 
using standard oral surgery techniques, including the use of elevators, forceps, and a high speed 
handpiece. Each animal was edentulated in each posterior mandibular sextant (first through 
fourth premolars). The surgical flaps were closed with a continuous 3/0 Vicril suture. Post 
operative analgesia was accomplished with 1 mg/Kg Nubane bid subcutaneously. The dogs 
continued to receive Pen BP and Gentocin for 7 days post surgery. 
At the time of implantation, anesthesia (IV and vaporizer), ventilator settings, IV fluids, 
antibiotics and analgesics were the same as described above. The oral cavity was rinsed twice 
with Betadine solution to obtain a relatively clean environment. The healed alveolar ridges of the 
mandibular posterior quadrants were exposed by raising subperiosteal flaps. When the crest of 
the alveolar ridge was less than 4 mm wide, the height of the ridge was reduced to provide an 
adequate width of bone for implant placement. 
A contra angle handpiece was used with 3i drills (BIOMET 3i, Palm Beach Gardens, FL) 
for implant site preparation.  Three surgical implant sites were prepared in each quadrant. A 
maximum cutting drill speed was used to minimize surgical trauma to the bone, and new drills 
were used for each animal. Three PS HA coated implants and three EPD nano HA coated 
implants were placed in each dog.  A total of six implants were placed in each mandible. After 
placement of the implants, the screw holes on the superior surface of the implants were covered 
with cover screws. The surgical area was liberally irrigated with normal saline to remove bone 
fragments and the tissue flaps are to be closed with continuous 3/0 Vicril sutures. 
At 12 weeks after implantation, 3 animals euthanized with potassium chloride, 
administered IV, under deep sodium pentothal anesthesia. Testing was performed within 24 
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hours after sacrificing the animals.  The tissue over the alveolar ridge was elevated and the most 
distal implant site identified. The mandibles were resected 20 mm posterior to the distal most 
implants, stripped of soft tissues and sectioned with a Gillings Holmes Sectioning Machine using 
a diamond wafering blade with copious normal saline irrigation. 
 To evaluate the interfacial strength of the implants at the bone-implant interface, pull out 
testing was performed using a MTS test frame (Model: Alliance RF/150, MTS).  Prior to testing, 
the bone-implant blocks were kept in cold normal saline. In preparation for testing, excess tissue 
was removed.  Each specimen was dissected with a table saw equipped with a small diamond 
blade until the implant was just at the surface and the implant axis perpendicular to the base 
plane of the bone–implant complex. Prior to each experiment, implant and transcortical contact 
dimensions were measured with a caliper gauge to determine the cortical bone–implant contact 
area. An implant pulling fixture was inserted through the topside of a stainless steel metal plate 
with a hole just large enough for the middle portion of the pulling fixture to tightly slip through.  
A bone-implant block was placed beneath the metal plate, and the implant pulling fixture was 
screwed into the implant.  The top of the implant pulling fixture protruding through the hole in 
the fixture was secured in a Jacobs Chuck attached to the MTS instrument.  At rate of 1 mm/min 
at a load of 5 kN, testing was performed until the bone–implant interface was ruptured.  
Significant differences in interfacial strength between the groups were analyzed using ANOVA, 
with Sheffe’s procedure as the post hoc test.  Differences were considered significant if P <0.05. 
To quantitatively evaluate bone formation, specimens were embedded in 
methylmethacrylate and sectioned parallel to their long axis using a Buehler Isomet equipped 
with a slow speed and diamond wafering blade.  Multiple-stain (Paragon Stain, Polysciences, 
Warrington, PA) was used as the primary stain.  The length of direct contact of bone to implant 
was measured histomorphometrically over a distance that corresponds to the average contact 
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length.  This length was calculated as a percentage of the axial length.  This measurement 
technique has been referred to as the profile contact length (PCL).  The length of integration and 
area of integration along a 100 µm boundary at the implant tissue interface was measured with 
digitally processed images.  Any interface exhibiting osseous tissue within 10 µm of the implant 
surface was considered osseointegrated.  Significant differences between the bone-implant 
contact lengths were analyzed using ANOVA, with Sheffe’s procedure as the post hoc test.  
Differences were considered significant if P <0.05. 
At 12 weeks, the remaining animals were anesthetized using the aforementioned 
procedures.  Custom made implant crown were cemented to implant abutments.  The implants 
were loaded for 9 months before sacrifice and data collection.  Interfacial strength and 
histological analysis of the bone to implant contact lengths were measured according to the same 
testing protocol described at 12 weeks. 
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Chapter 4. Results 
 
4.1. Pull Out Strength Testing 
All surgeries were uneventful, with no post-operative complications.  At 12 weeks after 
implantation, no statistical difference in pull out strength was observed between EPD nano HA 
(86.35 ± 28.07 lbf) and plasma sprayed HA coated implants (70.43 ± 16.65 lbf) (Figure 1 and 
Table 1).  
After loading for 9 months, it was observed that the interfacial strength of EPD nano HA 
coted implants (199.9 ± 35.1 lbf) was statistically higher (P <0.028) than the PS HA coated 
implants (121.14 ± 38.45 lbf) (Figure 1 and Table 2).  
 
4.2. Histological Evaluation of Bone Contact Length 
At 12 weeks implantation, no statistical significant difference in bone contact length was 
observed between EPD nano HA (97.6 ± 3.2%) and PS HA coated implants (95.6 ± 4.6%) (Table 
3).  No statistical significant difference in bone contact length was observed between EPD nano 
HA coated implants (91.8 ± 8.2%) and PS HA coated implants (84.3 ± 7.2%) after loading for 9 
months (Table 4).   
Figures 2 and 3 are representative histology of tissue-implant interface after 12 weeks 
implantation.  Figures 4 and 5 are representative histology of implant-bone interface after 1 year 
implantation.  Mature bone at the tissue-implant interface was observed for both implant groups 
at both time intervals. 
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Figure 1. Mean interfacial strength with standard deviations of EPD nano HA and PS HA coated 
implants after 12 weeks and 1 year of implantation. 
 
. 
 29
 
 
 
 
 
 
 
 
 
Table 1. Pull out strength (lbf ± SD) of different implant surfaces after 12 weeks implantation. 
 
Sample Pull Out Strength (lbf ± SD) 
EPD – 12 wk 86.35 ± 28.07 
PS – 12 wk 70.43 ± 16.65 
 
 
 
 
 
 
Table 2. Pull out strength (lbf ± SD) of different implant surfaces after 1 year implantation. 
Sample Pull Out Strength (lbf ± SD) 
EPD – 1 year 199.87 ± 35.13 
PS – 1 year 121.14 ± 38.45 
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Table 3. Mean bone contact length (% ± SD) of different implant surfaces after 12 weeks 
implantation. 
 
Sample Percent Bone Contact Length (± SD) 
EPD – 12 wk 97.6 ± 3.2 
PS – 12 wk 95.6 ± 4.6 
 
 
 
 
 
Table 4. Mean bone contact length (% ± SD) of different implant surfaces after 1 year 
implantation. 
 
Sample Percent Bone Contact Length (± SD) 
EPD – 12 wk 91.8 ± 8.2 
PS – 12 wk 84.3 ± 7.2 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Tissue-implant contact of plasma sprayed HA after 12 weeks. 
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Figure 3. Tissue-implant contact of EPD nano HA after 12 weeks. 
 
 
 
 
 
 32
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Tissue-implant contact of plasma sprayed HA after 1 year. 
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Figure 5.  Tissue-implant contact of EPD nano HA after 1 year. 
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Chapter 5. Discussion 
 
 
Tooth loss due to disease, trauma or otherwise congenitally absence is as primitive as the 
idea of replacement.  The early 1900’s marked the beginning of an era defined by modern 
methods of implant therapy.  The principal advancement was the identification of the ability of 
an implant to become “inseparately incorporated” into bone by Brånemark and associates, 
coining the term osseointergration.  They noted the importance of osseointegration to achieve 
and maintain implant bone anchorage under loading (Albrektsson et al. 1981).  Many implant 
studies at present concentrate on understanding the physiology of bone response to a variety of 
implant characteristics in order to enhance osseointegration for more dynamic treatment therapy 
involving dental and medical implants.  
Contemporary endosseous implants rely on bone for support and anchorage.  The 
composition of bone includes cells, extracellular matrix and minerals including calcium and 
phosphorus which are stored as hydroxyapatite (HA) crystals.  These components work together 
to heal and remodel bone after surgical insult associated with implant placement.  Block et al. 
(1997) described the integration of implants into bone by three phases; inflammatory, 
proliferative, and maturation phase. Within the first 42 days (inflammatory and proliferative 
phases), there is an increase of cellular activity, neovasculariztion, differentiation, proliferation, 
and production of connective tissue matrix that will ultimately be mineralized and remodeled.  
Sleats et al. (2006) confirmed the invasion and maximum activity of basic multicellular units in 
vivo after 4 weeks. 
  A basic knowledge of the cascade of events associated with bone remodeling correlated 
with the ability to synthetically reproduce HA has led to the development HA within the implant 
industry.   As implant technology evolves, so must the understanding of basic biologic principles 
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that control the ability of alveolar bone to tolerate and maintain artificial replacements of teeth.  
Implant design, composition and surface topography are among the most researched variables in 
finding the fastest and most durable bone anchorage for implants.   
Classified as a bioactive material, HA has the potential to allow for formation of new 
bone on its surface, forming a scaffold for bone ingrowth by exchanging ions to create a 
chemical as well as mechanical bond (Sykaras et al. 2000).  HA has been developed as a coating 
to combine its bioactivity with the strength of a metal substrate.  Its use continues to be a popular 
topic of research and debate.  Weinlaender et al. (1992) recognized that HA coated implants had 
a significantly higher percentage of bone contact as compared to different titanium surfaced 
implants, histologically noting a different pattern of bone growth.   
Among HA coatings are a multitude of depositional, compositional and topological 
differences. Cahn et al. (1993) described ideal HA attributes to include biocompatibility at its 
desired phase and crystallinity to enhance biological response, sufficient mechanical 
characteristics to maintain the integrity of the coating-implant interface, and adequate porosity to 
promote bone in growth and fixation.   Several methodologies of HA surface deposition now 
achieve these fundamental elements to produce surface coating capable of enhanced 
osseointegration.   Such methodologies include plasma spray (PS) and electrophoresis deposited 
(EPD) nano HA.  However, no general consensus is recognized about the superiority of one 
methodology’s ability to enhance osseointegration.  A multitude of tests exist to interpret each 
coating’s ability to augment osseointegration. 
Pull out testing is often used to infer information about the interfacial bond strength 
between bone and the implant interface.  The pull out test results observed in the present study 
for PS HA coated implants (70.43 + 16.65 lbf) was not statistically different from that found for 
EPD nano HA coated implants (86.35 + 28.07 lbf)  at 12 weeks after implantation, suggesting 
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comparable interfacial bond strengths. This was supported by the histological findings, which 
indicated no statistical difference in percent bone contact length between PS HA coated implants 
(95.6 + 4.6%) and EPD nano HA coated implants (97.6 + 3.2%) at 12 weeks after implantation. 
Hypothesis I.I and I.II were accepted: No difference in bone contact length will be observed 
between the EPD nano HA coated implants and PS HA coated implants following 12 weeks in 
situ before loading and no difference in and interfacial strength will be observed between the 
EPD nano HA coated implants and PS HA coated implants following 12 weeks in situ before 
loading. 
The results at 12 weeks are similar to other short term healing studies.  Wang et al. 
(2006) evaluated early bone apposition in vivo on PS HA and EPD nano HA coatings on 
titanium alloy’s.  Their research concluded that HA coatings only accelerated early stage 
mineralization (< 7 days). No difference was found at later stages (14 days) of mineralization 
rates.  They attributed these results to the difference in surface morphology and crystallinity 
created by unique coating processes.  Their ESEM images revealed plate-like shaped HA 
crystallites with a surface roughness of 1300 + 400 nm compared to the large globules of 
amorphous HA and indistinguishable HA crystallites with a surface roughness of 480 + 120 nm 
for the EPD nano HA coating.   
The interfacial strength of EPD nano HA coated implants (199.87 + 35.1 lbf) was 
statistically higher (P <0.028) than the commercial PS HA coated implants (121.14 + 38.45 lbf) 
after 1 year of integration and 9 months of loading. However, histological analysis reveal no 
statistical significant difference in bone contact length between EPD nano HA coated implants 
(91.8 + 8.2 %) and PS HA coated implants (84.3 + 7.2 %) after 1 year of integration and 9 
months of loading.  Histologically, no statistical difference in percent bone contact length exists 
even though EPD nano HA coated implant mean percent bone contact is 7.5 % higher.  
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However, pull out testing suggests stronger interfacial bond strength, inferring superior 
osseointegration of the EPD nano HA after 1 year of integration and 9 months of loading.  
Hyposthesis II.I was rejected: no difference in bone contact length will be observed between the 
EPD nano HA coated implants and PS HA coated implants after loading for 9 months. However, 
hypothesis II.II was accepted: no difference in interfacial strength will be observed between the 
EPD nano HA coated implants and PS HA coated implants after loading for 9 months.  To date, 
there is a lack of literature evaluating the superiority EPD nano HA coatings to other 
methodologies.  
PS HA and EPD nano HA coating methodologies have the ability to dramatically change 
structural and chemical properties by changing operational parameters. PS HA coatings are 
modified by power, currents, plasma work gas rate and composition, carrier gas rate, spraying 
time, particle size, speed of the plasma, distance between substrate and nozzle and cooling rate.  
The plasma work gas composition is the most important spraying parameter in regulating the 
desired crystallinity, heat content and coating thickness of HA (Ong et al. 2006).  EPD nano HA 
coatings are modified by the voltage/intensity relationship, deposition time, and composition, pH 
and temperature of the electrolyte (Meng et al. 2006).  Commercially available PS and EPD nano 
HA coatings can substantially differ in crystallinity, thickness and surface roughness among 
proprietors.  Each of these variables in itself can have a distinct affect in tissue response. 
Therefore, an evaluation of these coating attributes would be valuable to quantitatively and 
qualitatively differentiating and interpreting results.  
Osseointegration is dependant on the bioactivity and stability of the coating material.  
Many authors address these properties of coating materials, suggesting that HA’s bioactive 
influence expires after the initial stages of osseointegration (Wang et al. 2006).  Therefore, thick, 
soluble coatings as those achieved by PS may be unnecessary. The ability of EPD nano HA to be 
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thinner and more adherent than conventional PS HA coating could beneficially impact long term 
stability, even though its typically higher crystallinity values make it less soluble.  Although PS 
HA is an accepted and proven surface coating, EPD nano HA shows industrial and biological 
promise in the implant industry. 
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Chapter 6. Conclusion 
 
This study determined that the ultimate interfacial strength of plasma sprayed (PS) HA 
coated implants were similar to that of electrophoresis deposited (EPD) nano HA coated 
implants at 12 weeks. In addition, histomorphometric evaluation at 12 weeks indicated that the 
percent bone contact length for PS HA coated implants were similar to that of EPD nano HA 
coated implants. However, the ultimate interfacial strength of PS HA coated implants was 
statistically less than that of EPD nano HA coated implants at 1 year, even though 
histomorphometric evaluation at 12 weeks indicated that the percent bone contact length for PS 
HA coated implants was similar to that of EPD nano HA coated implants. It is concluded that 
EPD nano HA coating technology is a viable and promising process in use for medical and 
dental implants.  
Commercially available PS and EPD nano HA coatings can substantially differ in 
crystallinity, thickness and surface roughness among proprietors.  Each of these variables in 
itself can have a distinct affect in tissue response in any bioactive or biotolerant material. 
Therefore, an evaluation of these coating attributes would be valuable to quantitatively and 
qualitatively differentiating and interpreting results in future studies.  
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